Baird Medical Investment Financials - Benzinga

Baird Medical Investment Holdings Ltd

BDMDNASDAQ

Trade with Public

Trade with Public

$0.7900

-0.0001-0.01%

At close: Sep 22, 5:00 PM EST

$0.7127

-0.0774-9.8%

Pre-Market: 4:00 AM EST

Overview News Earnings Forecast EventsFinancialsSentiment Compare

Baird Medical Investment Financials

Baird Medical Investment (BDMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Baird Medical Investment FY EPS $(0.98) Down From $0.57 YoY, Sales $22.537M Down From $37.037M YoY

Baird Medical Investment (NASDAQ:BDMD) reported quarterly losses of $(0.98) per share. This is a 271.93 percent decrease over earnings of $0.57 per share from the same period last year. The company reported $22.537

Benzinga Newsdesk

PRO
Baird Medical Announces Preliminary H1 Revenue Results Of $13.1M, Up 13.8% YoY

Total revenues increased to US$13.1 million, representing 13.8% year-over-year growthNet income reached US$4.4 million, representing 85.8% year-over-year growthGUANGZHOU, China, Oct. 11, 2024 /PRNewswire/ -- Baird

Benzinga Newsdesk